J C Sodoyez - JoVE Visualize

Showing results (41-50 of 47) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 47 results.

Thymus|March 1, 1993

Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamilyV Geenen, I Achour, F Robert, et al.

The Journal of Clinical Investigation|August 1, 1987

Scintigraphic distribution of complexes of antiinsulin antibodies and 123I-insulin. In vivo studies in ratsF Sodoyez-Goffaux, J C Sodoyez, M Koch, et al.

The Journal of Clinical Endocrinology and Metabolism|February 19, 1998

Imaging of the buffering effect of insulin antibodies in the autoimmune hypoglycemic syndromeN Dozio, M Scavini, A Beretta, et al.

Metabolism: Clinical and Experimental|November 1, 1988

Glycerol-insulin raises circulating insulin antibodies in type I diabetic patients treated with permanently implanted devicesP Micossi, G Galimberti, M C Librenti, et al.

Science (New York, N.Y.)|April 24, 1987

Visualization of viral clearance in the living animalE M Verdin, E Maratos-Flier, C R Kahn, et al.

Pancreas|May 1, 1996

Abnormal circulating pancreatic enzyme activities in more than twenty-five percent of recent-onset insulin-dependent diabetic patients: association of hyperlipasemia with high-titer islet cell antibodies. Belgian Diabetes RegistryC Semakula, C L Vandewalle, C F Van Schravendijk, et al.

Pancreas|August 1, 1997

Proinsulin and its conversion intermediates in human pancreas and isolated islet tissue: kinetics and steady-state analysisX Hou, Z Ling, Y Zambre, et al.

Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 47 results.

Thymus|March 1, 1993

Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamilyV Geenen, I Achour, F Robert, et al.

The Journal of Clinical Investigation|August 1, 1987

Scintigraphic distribution of complexes of antiinsulin antibodies and 123I-insulin. In vivo studies in ratsF Sodoyez-Goffaux, J C Sodoyez, M Koch, et al.

The Journal of Clinical Endocrinology and Metabolism|February 19, 1998

Imaging of the buffering effect of insulin antibodies in the autoimmune hypoglycemic syndromeN Dozio, M Scavini, A Beretta, et al.

Metabolism: Clinical and Experimental|November 1, 1988

Glycerol-insulin raises circulating insulin antibodies in type I diabetic patients treated with permanently implanted devicesP Micossi, G Galimberti, M C Librenti, et al.

Science (New York, N.Y.)|April 24, 1987

Visualization of viral clearance in the living animalE M Verdin, E Maratos-Flier, C R Kahn, et al.

Pancreas|May 1, 1996

Abnormal circulating pancreatic enzyme activities in more than twenty-five percent of recent-onset insulin-dependent diabetic patients: association of hyperlipasemia with high-titer islet cell antibodies. Belgian Diabetes RegistryC Semakula, C L Vandewalle, C F Van Schravendijk, et al.

Pancreas|August 1, 1997

Proinsulin and its conversion intermediates in human pancreas and isolated islet tissue: kinetics and steady-state analysisX Hou, Z Ling, Y Zambre, et al.

Pageof 5